Provenge, the first immunotherapy drug to receive FDA approval for use in patients, had its origins decades ago in the lab of Edgar Engleman. Photo by Timothy Archibald /2019
sp19 provenge twitter
Popular posts
Runaway immune reactions cause long COVID breathing problems
Researchers at Stanford Medicine have investigated the mechanism of pulmonary fibrosis caused by long COVID.
‘Cyclic sighing’ can help breathe away anxiety
Stanford Medicine researchers showed that five minutes a day of breathing exercises can reduce overall anxiety and improve mood.